Truist raised the firm’s price target on Tenet Healthcare (THC) to $92 from $84 and keeps a Buy rating on the shares as part of a broader research note on Healthcare Services names. The analyst cites the recent market moves and multiples following commentary from both UnitedHealth (UNH) and Humana (HUM) around an uptick in utilization, reducing targets in Managed Care and bumping Hospital targets while remaining “broadly bullish” on both groups.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on THC:
- Tenet management show ‘excitement, optimism’ for current trends, says Jefferies
- Tenet Healthcare price target raised to $81 from $65 at Deutsche Bank
- Tenet Healthcare price target raised to $77 from $64 at Stephens
- Tenet Healthcare price target raised to $84 from $74 at Truist
- Tenet Healthcare price target raised to $85 from $72 at Raymond James